No Detail Found!

A Longitudinal Follow-up Study of Anti-depressant Drugs Causing Hepatotoxicity in Patients with Major Depressive Disorders

Author(s)
Javeria Farooq Peoples Medical University of Medical & Health Sciences for Women, Nawabshah, Shaheed Benazir Abad, Pakistan
Ball Chand Peoples Medical University of Medical & Health Sciences for Women, Nawabshah, Shaheed Benazir Abad, Pakistan
Bashir Ahmed Khuhro Peoples Medical University of Medical & Health Sciences for Women, Nawabshah, Shaheed Benazir Abad, Pakistan
Abdul Samad Peoples Medical University of Medical & Health Sciences for Women, Nawabshah, Shaheed Benazir Abad, Pakistan
Farooq Baig Muhammad Medical College, Mirpurkhas, Sindh, Pakistan
Geeta Kumari Department of Medicine Dr. Ruth K.M. Pfau Civil Hospital Karachi, Pakistan
Abstract
Aim: To determine and compare hepatotoxic effects caused by escitalopram versus sertraline in patients with major depressive disorder. Study Design: Comparative longitudinal study Place and Duration of Study: Department of Pharmacology, Basic Medical Sciences Institute (BMSI) & Neuropsychiatry Ward of Jinnah Postgraduate Medical Centre (JPMC) Karachi from January 2017 to December 2017. Methods: One hundred and twenty eight patients divided into four groups; group 1 (recent users for a period of >1 month to =3 months), group 2 (drug users for a period of >6 months to =9 months), group 3 (drug users for a period of >1 year to =2 years and group 4 (drug users for a period of >2years to =5 years.) and each group consists of 32 patients. Out of these 32 patients, 16 patients were escitalopram users (10-20mg) and 16 patients were sertraline users (50mg). Out of these 16 patients, 8 patients were males and 8 patients were females. Results:The mean comparison of LFT parameters between two treatment groups results showed in escitalopram samples, mean±SD for Bilirubin was 0.91±0.38, SGPT 61.24±12.0, alkaline phosphatase 213.63±53.03, whereas in treatment group sertraline, mean±SD of bilirubin was 0.69±0.16, SGPT 36.88±9.34, alkaline phosphatase 221.69±108.9, there was significant mean difference observed for bilirubin and SGPT between two treatment groups with p-value less than 0.01. Conclusion:Both escitalopram and sertraline can cause hepatotoxicity.
Publication Details
Page(s) 458-461
DOI DOI not available
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 14, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
Major depressive disorder (MDD), Selective serotonin reuptake inhibitors (SSRIs), Liver function test (LFT)
0

Citations

0

Downloads

113

Views